Medicine
Ovidrel 250 mcg/0.5 mL injection
Ovidrel 250 mcg/0.5 mL injection is a prescription medicine containing Choriogonadotropin alfa for subcutaneous use, marketed by EMD Serono, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store in original package.
Key facts
- Active ingredient (INN)
- Choriogonadotropin alfa
- Brand
- Ovidrel
- Strength
- 250 mcg/0.5 mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Packs
- 1 syringe of 0.5 mL
- Marketing authorisation holder
- EMD Serono
- Manufacturer
- EMD Serono
- Origin register
- US FDA, United States
- Storage
- Store in original package.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- G03GA01 Chorionic gonadotropin
- HS code (indicative)
- 3004.39Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 6 October 2003
- Identifiers
- RxCUI 727505, 727507DailyMed set ID a683e58a-63ea-44b8-a326-1a99a537bcf2NDC 44087-1150Application BLA021149
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 syringe, glass in 1 carton / .5 mL in 1 syringe, glass | 44087-1150-1 | EMD Serono | 6 October 2003 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Choriogonadotropin alfa
Clinical summary
Choriogonadotropin alfa is a gonadotropin indicated for the induction of final follicular maturation and early luteinization in infertile women, among other approved uses. It is available as kits and injection for subcutaneous use. MedsAcross supplies Choriogonadotropin alfa for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Choriogonadotropin alfaFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Ovidrel prescribing information (EMD Serono) · U.S. National Library of Medicine, DailyMed
- Ovitrelle: European public assessment report (EPAR) · European Medicines Agency
Need Ovidrel 250 mcg/0.5 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.